Internal Medicine, Gastroenterology · Chicago, IL
NPI
1992868418
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
676 N Saint Clair St Ste 650
Chicago, IL, 60611
Phone (312) 695-5620
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
408 services
Medicare patients, 2024
202
Average age 72
Drug cost, 2024
$3.1M
846 prescriptions
Company payments, 2025
$269K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen B Hanauer was code 99215 (office e&m - established), 127 times for 74 patients. In total Stephen B Hanauer billed 408 services in 20 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 127 | 74 | $117.06 | $15K |
| 99214 Office E&M - Established | Facility | 97 | 77 | $75.88 | $7,361 |
| 45380 Lower GI Endoscopy - Other | Facility | 35 | 35 | $150.96 | $5,284 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 33 | 33 | $5.42 | $179 |
| 99232 Hospital E&M - Subsequent | Facility | 31 | 15 | $67.62 | $2,096 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 20 | 20 | $196.65 | $3,933 |
| 45385 Colonoscopy - Lesion Removal | Facility | 12 | 12 | $231.48 | $2,778 |
By year: 2022 $38K for 369 services; 2023 $37K for 350 services; 2024 $41K for 408 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephen B Hanauer prescribed most often to Medicare patients was Mesalamine, with 136 prescriptions and refills. In total Stephen B Hanauer wrote 846 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mesalamine Generic | 136 | 328 | 33 | $84K |
| Humira(Cf) Pen Adalimumab | 63 | 80 | Under 11 | $973K |
| Prednisone Generic | 48 | 99 | 14 | $596 |
| Stelara Ustekinumab | 42 | 69 | Under 11 | $1.1M |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 32 | 32 | 31 | $1,936 |
| Ciprofloxacin Hcl Generic | 29 | 33 | Under 11 | $382 |
| Budesonide Dr Budesonide | 25 | 28 | Under 11 | $2,665 |
| Pantoprazole Sodium Generic | 24 | 64 | Under 11 | $407 |
| Rinvoq Upadacitinib | 23 | 23 | Under 11 | $201K |
| Sulfasalazine Generic | 22 | 50 | Under 11 | $1,003 |
| Skyrizi On-Body Risankizumab-Rzaa | 22 | 39 | Under 11 | $461K |
| Loperamide Loperamide Hcl | 22 | 31 | Under 11 | $776 |
| Omeprazole Generic | 21 | 61 | Under 11 | $260 |
| Azathioprine Generic | 19 | 57 | Under 11 | $1,173 |
| Methotrexate Methotrexate Sodium | 18 | 46 | Under 11 | $440 |
Brand drugs: - claims; generic drugs: 547 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen B Hanauer $269K ($260K in general payments such as food, travel and fees and $8,360 for research) from 15 companies. The largest payer was Lilly USA, LLC with $89K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 64 | $89K |
| Janssen Biotech, Inc. JNJ | 44 | $66K |
| Abbvie Inc. ABBV | 30 | $43K |
| Celltrion USA Inc. 068270.KS | 9 | $18K |
| Biocon Biologics Inc | 2 | $11K |
| Gilead Sciences, Inc. GILD | 5 | $11K |
| Eli Lilly and Company LLY | 3 | $11K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $6,935 |
| Pfizer Inc. PFE | 3 | $4,760 |
| Merck Sharp & Dohme LLC MRK | 2 | $4,303 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.